Therapy of Angiosarcoma with Thalidomide and Lenalidomide

Angiosarcoma is an uncommon malignancy with a poor prognosis. Systemic therapy options for patients with metastatic disease generally have limited effectiveness. In this case study, a 73-year-old male with metastatic angiosarcoma who previously declined chemotherapy and developed progressive disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattes, M. Jules, Mattes, Jeffrey A., Groisberg, Roman, Mattes, Malcolm D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647127/
https://www.ncbi.nlm.nih.gov/pubmed/34949999
http://dx.doi.org/10.1159/000519970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647127/
https://www.ncbi.nlm.nih.gov/pubmed/34949999
http://dx.doi.org/10.1159/000519970

Ejemplares similares